Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-24

Clinical Trial Update: Active Drug Surveillance Program of Ferriprox Use

View source ↗

Summary

The Active Drug Surveillance Program for Ferriprox (deferiprone) use in transfusional iron overload has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FERRIPROX (deferiprone)

Snippet

Sponsor: ApoPharma | Conditions: Transfusional Iron Overload | Status: COMPLETED